日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
HongKong Comment(1)

HK should become a world-class pioneer of Chinese medicine

HK Edition | Updated: 2017-12-01 06:07
Share
Share - WeChat

Against a backdrop of growing health problems brought by a rapidly aging population both in Hong Kong and worldwide, which are aggravated by drastic changes in the environment and numerous human genetic mutations, the continuous development of medical technology and innovation plays a crucial role in sustaining health and saving lives.

Hong Kong's healthcare system and its management are second to none when compared with other developed economies. The Department of Health attaches great importance to fostering partnerships with outstanding healthcare professionals and bodies, both in the city and abroad, in its effort to improve the health of people in Hong Kong. This is also to keep Chief Executive Carrie Lam Cheng Yuet-ngor's "We Connect" manifesto promise to enhance the role of Chinese medicine in the public healthcare system so as to provide top-quality healthcare services to the public.

The Hospital Authority reported that it used up the HK$49-billion grant from the government for the 2014-15 fiscal year to enhance medical services in public hospitals. In the following fiscal year, demand for medical services continued to rise with the number of inpatient discharges and deaths hitting 1.67 million, a rise of about 4 percent from 2014-15. The number of specialist and general outpatient attendances reached 7.31 million and 5.98 million, respectively. Supported by a relatively small budget, equivalent to just 2.5 percent of Hong Kong's GDP, the authority serves nearly 90 percent of all inpatient healthcare needs in the city. These contrasting figures reflect the prevalence of chronic diseases on one hand and suggest a shortage of medical staff on the other. It is generally agreed that the Food and Health Bureau should implement a long-term policy on building up professional healthcare manpower, which should include measures to boost the professional development of Chinese medicine practitioners and ensure all locally trained Chinese medicine graduates can be employed in Hong Kong's public healthcare system.

Since the government is initiating reforms in the healthcare and medical system, it is a good time to consider repositioning Chinese medicine so it can help the medical system cope with rising capacity pressure amid manpower constraints. It is suggested the Hospital Authority and Food and Health Bureau raise the bar for Chinese medicine industry development in Hong Kong; they should seek ways to strengthen cooperation with Chinese mainland hospitals and other medical institutes in areas such as research and development of pharmaceuticals, prescriptions, medical equipment and latest medical technologies as well as providing specialist training for Chinese medicine practitioners; they should also facilitate the exchange of expertise in healthcare management and policy development for medical services in public hospitals. By enhancing cooperation between the sides, Hong Kong can expand the coverage of its healthcare services and strengthen its capacity and capabilities. Ultimately, Chinese medicine will contribute greatly to the continuous improvement and sustainable development of Hong Kong's healthcare system.

Aiming to provide world-class medical services to Hong Kong residents, Hong Kong Science and Technology Parks Corporation and Hong Kong Chinese Medical Science Academy are vigorously engaged in medical and pharmaceutical R&D, especially in colorectal cancer treatment. It is suggested that any R&D achievements on Chinese pharmaceuticals and medical technology should be promoted and exported worldwide so as to facilitate technology transfer and help nurture talents. It is suggested R&D results on minimally invasive surgery will also be promoted across the Asia-Pacific region, particularly to mainland surgeons. More frequent exchange on management experience and technology will help improve the standard and quality of Hong Kong's medical management and develop the city into an Asian pharmaceutical R&D center.

In developing the city's healthcare industry, the Hong Kong government is well-advised to encourage investors from other developed economies to invest in the areas of Chinese pharmaceutical products and services. The government may also consider providing financial support to small and medium enterprises in the pharmaceutical industry as incentive to encourage the development of Chinese medicine products and services. It may also encourage startup companies to invest in the area of medical technology R&D to accelerate the development of Chinese medicine in Hong Kong. Further development of Chinese pharmaceutical products and services will provide new impetus to Hong Kong's innovative healthcare system and create new sources of revenue for the special administrative region government's treasury.

(HK Edition 12/01/2017 page12)

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 欧美一区二区三区不卡免费 | 狠狠干综合 | 日本中文在线 | 色综合久久中文字幕综合网 | 欧美日韩高清不卡一区二区三区 | 91在线免费观看 | 亚洲 欧美 中文字幕 | 精品成人免费一区二区在线播放 | 国产a级一级久久毛片 | 日朝欧美亚洲精品 | 妞干网在线观看 | 亚洲欧洲中文日韩 | 久久6国产 | 日本又黄又粗暴的gif动态图含羞 | 国产在线网 | 日本网站在线播放 | 中文字幕精品一区二区三区精品 | 久九精品| 99久久精品日本一区二区免费 | 一区二区三区视频在线观看 | 日日日日日| 91茄子国产线观看免费 | 亚州综合网 | 欧美一区二区免费电影 | 精品免费福利视频 | 亚洲欧美日韩在线 | 亚洲热综合 | 美女被免费网站在线视频九色 | 欧美日韩一区二区中文字幕 | 国产三级在线播放 | 亚洲综合视频在线观看 | 亚洲精品二三区 | 午夜免费视频 | 国产福利精品在线观看 | 亚洲播播 | 一区二区三区四区免费看 | 亚洲日韩aⅴ在线视频 | 日色视频 | 亚洲一区二区三区免费视频 | 日韩欧美二区 | 99热这里有免费国产精品 |